BK Polyomavirus Replication in Renal Tubular Epithelial Cells Is Inhibited by Sirolimus, but Activated by Tacrolimus Through a Pathway Involving FKBP-12-Reference-Cited by-同舟云学术

BK Polyomavirus Replication in Renal Tubular Epithelial Cells Is Inhibited by Sirolimus, but Activated by Tacrolimus Through a Pathway Involving FKBP-12

Published:2015-12-07 Issue:3 Volume:16 Page:821-832
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Hirsch H. H.¹²³,Yakhontova K.¹,Lu M.¹,Manzetti J.¹

Affiliation:

1. Transplantation & Clinical Virology; Department of Biomedicine (Haus Petersplatz); University of Basel; Basel Switzerland

2. Division Infection Diagnostics; Department of Biomedicine (Haus Petersplatz); University of Basel; Basel Switzerland

3. Infectious Diseases & Hospital Epidemiology; University Hospital Basel; Basel Switzerland

Funder

University of Basel to HHH

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajt.13541/fullpdf

Reference61 articles.

1. BK virus nephropathy-Polyomavirus adding insult to injury;Fishman;N Engl J Med,2002

2. The decade of polyomavirus BK-associated nephropathy: State of affairs;Ramos;Transplantation,2009

3. Management of polyomavirus-associated nephropathy in renal transplant recipients;Kuypers;Nat Rev Nephrol,2012

4. Transient versus persistent BK viremia and long-term outcomes after kidney and kidney-pancreas transplantation;Elfadawy;Clin J Am Soc Nephrol,2014

5. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients;Hirsch;N Engl J Med,2002

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacodynamic Effect of mTOR Inhibition-based Immunosuppressive Therapy on T- and B-cell Subsets After Renal Transplantation;Transplantation Direct;2024-06-20

2. A comparative analysis of clinical outcomes between conversion to mTOR inhibitor and calcineurin inhibitor reduction in managing BK viremia among kidney transplant patients;Scientific Reports;2024-06-04

3. The Second International Consensus Guidelines on the Management of BK Polyomavirus in Kidney Transplantation;Transplantation;2024-04-12

4. Association of UGT1A Gene Polymorphisms with BKV Infection in Renal Transplantation Recipients;Current Drug Metabolism;2024-03

5. A Head-to-head Comparison of De Novo Sirolimus or Everolimus Plus Reduced-dose Tacrolimus in Kidney Transplant Recipients: A Prospective and Randomized Trial;Transplantation;2023-08-01